Among patients with rheumatoid arthritis-associated interstitial lung disease, there was no significant difference in the ...

Tocilizumab-anoh is approved for multiple conditions, including rheumatoid arthritis and COVID-19, in intravenous and subcutaneous formulations. Phase 3 study confirmed biosimilarity between ...

While the strategies didn’t lower NT-proBNP after PCI in acute MI patients, they may suggest a way forward for intervening early.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The economic and societal impacts of emerging infectious ...

A combination of tocilizumab plus prednisone-tapered therapy was superior to placebo plus steroid taper for achieving glucocorticoid-free remission in giant-cell arteritis (GCA), the phase 3 ...

History of neutropenia with methotrexate, concurrent treatment with synthetic disease-modifying antirheumatic drugs (sDMARDs), and tocilizumab were risk factors for developing neutropenia while on ...

About half of patients with steroid-dependent polymyalgia rheumatica (PMR) were able to get off steroids altogether when they were started on tocilizumab (Actemra) infusions, which also improved ...

An initial crop of clinical trials testing an anti-inflammatory drug against COVID-19 do not look promising. The best available evidence among these trials “doesn’t show that this drug is beneficial,” ...

A pair of human colon cells infected with SARS-CoV-2 produce filopodia (white) containing viral particles. The treatment of severe Covid-19 has proven difficult over the past three years, illustrated ...

The Appraisal Committee reviewed the data available on the clinical and cost effectiveness of tocilizumab, having considered evidence on the nature of systemic JIA and the value placed on the benefits ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Tocilizumab (Actemra/RoActemra) was not found to have any clear role as a treatment for COVID-19 in ...